Region-specific neurotrophin imbalances in Alzheimer disease Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas

被引:429
作者
Hock, C
Heese, K
Hulette, C
Rosenberg, C
Otten, U
机构
[1] Univ Zurich, Dept Psychiat Res, CH-8029 Zurich, Switzerland
[2] Univ Basel, Dept Physiol, Basel, Switzerland
[3] Duke Univ, Med Ctr, Kathleen Price Bryan Brain Bank, Durham, NC USA
关键词
D O I
10.1001/archneur.57.6.846
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4/5 (NT-4/5) are members of the neurotrophin gene family that support the survival of specific neuronal populations, including those that are affected by neurodegeneration in Alzheimer disease (AD). Objective: To determine whether neurotrophin protein levels are altered in the AD-affected brain compared with control brains. Methods: We quantitated protein levels of NGF, BDNF, NT-3, and NT-4/5, and calculated neurotrophin/NT-3 ratios in AD-affected postmortem hippocampus, frontal and parietal cortex, and cerebellum, and compared them with age-matched control tissue (patients with AD/controls: hippocampus, 9/9 cases; frontal cortex, 19/9; parietal cortex 8/5; and cerebellum 5/7, respectively). We applied highly sensitive and specific enzyme-linked immunosorbent assays in rapid-autopsy-derived brain tissue (mean+/-SD postmortem interval, 2.57 +/- 1.75 h, n = 71) to minimize postmortem proteolytic activity. Results: Levels of BDNF were significantly reduced in hippocampus and parietal cortex (P<.001, and P<.01) as well as BDNF/NT-3 ratios in frontal and parietal cortices (P<.05, and P<.01) in the group with AD compared with the control group. Levels of NGF and NGF/NT-3 ratio n ere significantly elevated in the group with AD compared with the control group in the hippocampus and frontal cortex (P<.001). Levels of NT-4/5 and the NT-4/NT-3 ratio were slightly reduced in hippocampus and cerebellum in the group with AD compared with the control group (P<.05). In contrast, the levels of NT-3 were unchanged in all brain regions investigated Conclusion: Decreased levels of BDNF may constitute a lack of trophic support and, thus, may contribute to the degeneration of specific neuronal populations in the AD-affected brain, including the basal forebrain cholinergic system.
引用
收藏
页码:846 / 851
页数:6
相关论文
共 31 条
[1]   NEUROTROPHIN-3 PREVENTS THE DEATH OF ADULT CENTRAL NORADRENERGIC NEURONS IN-VIVO [J].
ARENAS, E ;
PERSSON, H .
NATURE, 1994, 367 (6461) :368-371
[2]  
BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.ne.18.030195.001255
[3]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[4]   REGULATION OF NEUROPEPTIDES IN ADULT-RAT FOREBRAIN BY THE NEUROTROPHINS BDNF AND NGF [J].
CROLL, SD ;
WIEGAND, SJ ;
ANDERSON, KD ;
LINDSAY, RM ;
NAWA, H .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1994, 6 (08) :1343-1353
[5]   Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex [J].
Fahnestock, M ;
Scott, SA ;
Jette, N ;
Weingartner, JA ;
Crutcher, KA .
MOLECULAR BRAIN RESEARCH, 1996, 42 (01) :175-178
[6]   NERVE GROWTH-FACTOR MESSENGER-RNA IN PERIPHERAL AND CENTRAL RAT-TISSUES AND IN THE HUMAN CENTRAL-NERVOUS-SYSTEM - LESION EFFECTS IN THE RAT-BRAIN AND LEVELS IN ALZHEIMERS-DISEASE [J].
GOEDERT, M ;
FINE, A ;
HUNT, SP ;
ULLRICH, A .
MOLECULAR BRAIN RESEARCH, 1986, 1 (01) :85-92
[7]  
Heese K, 1998, J NEUROCHEM, V70, P699
[8]  
HEESE K, 1998, NEURAL NOTES, V3, P21
[9]   Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease [J].
Hock, C ;
Heese, K ;
Müller-Spahn, F ;
Hulette, C ;
Rosenberg, C ;
Otten, U .
NEUROSCIENCE LETTERS, 1998, 241 (2-3) :151-154
[10]  
Hoener MC, 1996, BRAIN RES, V728, P47